Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D008055:Lipids / Q000097:blood*; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D009539:Nicotinic Acids; D011720:Pyrazoles; D013501:Surface-Active Agents; D014280:Triglycerides; D002784:Cholesterol; D004837:Epinephrine